Latest in Jim Cramer names a drug stock that could be the best for 2025, and it's not Eli Lilly
Sort by
1,644 items
-
Jim Cramer reflects on how the Biden administration might have affected the market
CNBC's Jim Cramer on Thursday mused about how President Joe Biden impacted the market.CNBC - 7h -
Jim Cramer names a drug stock that could be the best for 2025, and it's not Eli Lilly
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.CNBC - 14h -
Medicare's new $2,000 cap on out-of-pocket drug costs could save patients thousands, AARP says
The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid arthritis, and other conditions.CNBC - 19h -
Jim Cramer says to stay focused on earnings reports after Wednesday's stock rally
CNBC's Jim Cramer examined Wednesday's market rally and stressed that it's important to stay focused on corporate earnings and commentary from management.CNBC - 1d -
Why Visa’s stock could be a better play than Mastercard’s this year
Visa’s more U.S.-focused business looks like an asset, according to Seaport Research.MarketWatch - 2d -
Eli Lilly CEO expects new weight loss pill to be approved next year
Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which dominate the weight loss drug market.CNBC - 3d -
Eli Lilly strikes deal for cancer treatment, gives timeline for weight loss pill
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.CNBC - 3d -
The 7 best water flossers of 2025
Are water flossers as effective as dental floss? Dentists explain, and share how to properly use them.NBC News - 3d -
2025 NFL playoffs: Jim Nantz to reach incredible career milestone during Broncos vs. Bills wild-card game
The broadcast legend is on the precipice of historyCBS Sports - 4d -
Walgreens’ stock could see its best day ever. Is a turnaround really in store?
Walgreens was the worst stock in the S&P 500 last year. An analyst writes that it’s still “premature to say that Walgreens is on a stable path to growth” despite upbeat earnings.MarketWatch - 6d -
-
Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss.CNBC - Jan. 9 -
Experts Name ‘Worst in Show’ Products at CES 2025
Some gadgets debuting at the giant trade show put your data at risk and cause waste, privacy advocates say.Inc. - Jan. 9 -
Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly
Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment costs about $1,000 a month without insurance.MarketWatch - Jan. 9 -
Micron’s stock leads the S&P 500 for 2025. Here’s why more gains could follow.
An analyst sees big upside ahead, fueled by rapid growth in high-bandwidth memory for AI.MarketWatch - Jan. 9 -
Could Josh McDaniels take Patriots' OC job if Vrabel is named coach?
Might the Patriots bring on a pair of familiar faces at head coach and offensive coordinator? Here's the latest buzz around Josh McDaniels.Yahoo Sports - Jan. 9 -
Wall Street names 13 of our stocks 'top picks' for 2025 — here's the list and our takes
These are names analysts say can not only weather any headwinds but will thrive in the new year.CNBC - Jan. 9 -
Jim Cramer opines on TikTok ban: 'Let's just call it anybody’s ballgame'
CNBC's Jim Cramer on Wednesday gave investors his read on the future of TikTok.CNBC - Jan. 8 -
Eli Lilly's lead in the obesity race has grown. Its recent stock performance says otherwise
Eli Lilly has been one of the worst-performing Club stocks over the past six months.CNBC - Jan. 8 -
Struggling health stock perks up — and why Jim Cramer wants to buy more Disney
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.CNBC - Jan. 8 -
Jim Cramer's top 10 things to watch Wednesday — the special market froth edition
We're also watching jobs. Friday's employment report could determine whether Wall Street sees Fed rate cuts as appropriate or heavy-handed.CNBC - Jan. 8 -
Tesla and Nvidia dominated the stock market last year. Why more pedestrian names can shine in 2025.
The average S&P 500 stock had a tough go of it in December. But better times could lie ahead in 2025.MarketWatch - Jan. 8 -
Jim Cramer says Nvidia's pullback could be a good chance to buy
CNBC's Jim Cramer extolled Nvidia's stock and reviewed its Tuesday action, saying the decline was unrelated to the company and its prospects.CNBC - Jan. 8 -
Jim Cramer looks ahead to Friday's employment data: 'We’re at the mercy of macro numbers'
CNBC's Jim Cramer reviewed Tuesday's market-wide decline.CNBC - Jan. 7 -
Ketamine could be reclassified as Class A drug
Illegal use of the drug reached record levels last year, the Home Office said.BBC News - Jan. 7 -
Bank of America’s stock could go up 20% in 2025, says this analyst
UBS’s Erika Najarian upgrades Bank of America to buy from neutralMarketWatch - Jan. 7 -
Jim Cramer's top 10 things to watch in the stock market Tuesday
Wall Street was looking at a muted open Tuesday after the S&P 500 and the Nasdaq closed higher for a second straight sessionCNBC - Jan. 7 -
Jim Cramer explores why consumer goods stocks are seeing losses
CNBC's Jim Cramer reviewed Monday's market action and gave his take on why a large swath of stocks are notching losses.CNBC - Jan. 6 -
GrabAGun names Donald Trump Jr. as adviser in bid to lift stock-listing visibility
GrabAGun on Monday named Donald J. Trump Jr. an adviser and announced he will be an equity shareholder once the online gun retailer goes public in the coming months to become the latest stock with ...MarketWatch - Jan. 6 -
Colts' Jim Irsay declares Shane Steichen, Chris Ballard will return as team's head coach, GM for 2025 season
No sweeping changes in Indy for nowCBS Sports - Jan. 6 -
Transcript: Reps. Mike Turner and Jim Himes "Face the Nation with Margaret Brennan," Jan. 5, 2025
The following is a transcript of an interview with Reps. Mike Turner, Republican of Ohio, and Jim Himes, Democrat of Connecticut, on "Face the Nation with Margaret Brennan" that aired on Jan. 5, 2025.CBS News - Jan. 5 -
These are the space stocks to watch in 2025
After a big year for SpaceX — and one of misfortune for Boeing — here’s what to expect in the new year.MarketWatch - Jan. 4 -
How Jim Cramer views Corona brewer Constellation Brands after surgeon general warning
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.CNBC - Jan. 3 -
A Stock Market Boom Could Arrive in 2025, According to History
The S&P 500 has turned negative only twice after an annual return of 20 percent or more.Inc. - Jan. 3 -
Jim Cramer's top 10 things to watch in the stock market Friday
Shipments from Tesla's Shanghai factory posted their first annual decline. A study on GLP-1 user behavior also caught my eye.CNBC - Jan. 3 -
Our best and worst stocks in 2024 actually had a lot in common
AI spending, the Federal Reserve's easing campaign and Donald Trump's election victory were key themes for the market and our stocks in 2024.CNBC - Jan. 3 -
The 17 Best EVs Coming in 2025
After Jaguar’s chaotic relaunch and the pomp and theater of Tesla’s Cybercab reveal party, it’s hard to imagine the coming year will top 2024—until you see our picks for the best EVs of 2025.Wired - Jan. 1 -
365 Best Inspirational Quotes for 2025
“Whatever you do, don’t wake up at 65 years old and think about what you should have done with your life.”Inc. - Jan. 1
